Tag: clinical trials

Documentation Deviations: Missing Signatures, Dates and Source Gaps

November 20, 2025November 16, 2025 digi

Documentation Deviations: Missing Signatures, Dates and Source Gaps Documentation Deviations: Missing Signatures, Dates and Source Gaps In the realms of clinical trial services, documentation integrity is paramount. Regulatory bodies such as the FDA, EMA, and MHRA stress the importance of maintaining comprehensive and accurate documents to ensure trials adhere to Good Clinical Practice (GCP). Regulatory…

Common Deviation Patterns & Fixes

DCT-Specific Deviation Patterns in Telehealth and Remote Assessments

November 20, 2025November 16, 2025 digi

DCT-Specific Deviation Patterns in Telehealth and Remote Assessments As the clinical research field increasingly embraces decentralized clinical trials (DCTs), understanding deviation patterns specific to telehealth and remote assessments becomes crucial. Protocol deviations can jeopardize the reliability and integrity of clinical trial results. This tutorial serves as a comprehensive guide to identifying common deviation patterns and…

Common Deviation Patterns & Fixes

Digital Tools and Automation to Streamline Publication Policies & Authorship Criteria

November 20, 2025November 16, 2025 digi

Digital Tools and Automation to Streamline Publication Policies & Authorship Criteria Digital Tools and Automation to Streamline Publication Policies & Authorship Criteria The integration of digital tools and automation into clinical trial processes is transforming the way publication policies and authorship criteria are managed. In a regulatory landscape governed by ICH-GCP standards, as well as…

Publication Policies & Authorship Criteria

Inspection and Audit Readiness: Documenting Publication Policies & Authorship Criteria for Regulators

November 20, 2025November 16, 2025 digi

Inspection and Audit Readiness: Documenting Publication Policies & Authorship Criteria for Regulators Inspection and Audit Readiness: Documenting Publication Policies & Authorship Criteria for Regulators In the increasingly regulated world of clinical trials, ensuring compliance with the ever-evolving standards is paramount. Not only do regulatory bodies like the FDA and EMA enforce guidelines for conducting clinical…

Publication Policies & Authorship Criteria

Common Deficiencies in ICFs, Assent & Short Forms Highlighted in FDA, EMA and MHRA Inspections

November 20, 2025November 16, 2025 digi

Common Deficiencies in ICFs, Assent & Short Forms Highlighted in FDA, EMA and MHRA Inspections Common Deficiencies in ICFs, Assent & Short Forms Highlighted in FDA, EMA and MHRA Inspections Introduction to Informed Consent Forms (ICFs) and Regulatory Standards The process of obtaining informed consent is a fundamental ethical requirement in clinical trials, highlighting the…

ICFs, Assent & Short Forms

Safety Assessment Deviations: Missed Vitals, Labs and AE Follow-Up

November 20, 2025November 16, 2025 digi

Safety Assessment Deviations: Missed Vitals, Labs and AE Follow-Up Safety Assessment Deviations: Missed Vitals, Labs and AE Follow-Up In the context of clinical trials, safety assessments are critical to ensuring patient well-being and the integrity of trial results. Deviations in these assessments can lead to significant ramifications for both the conduct of the study and…

Common Deviation Patterns & Fixes

Eligibility Criteria Deviations: Impact on Subject Inclusion and Data Integrity

November 20, 2025November 16, 2025 digi

Eligibility Criteria Deviations: Impact on Subject Inclusion and Data Integrity Eligibility Criteria Deviations: Impact on Subject Inclusion and Data Integrity Eligibility criteria are a fundamental component of clinical trial design, serving to define the population for which the study results will be applicable. However, deviations from these criteria can significantly impact subject inclusion and, ultimately,…

Common Deviation Patterns & Fixes

Aligning Publication Policies & Authorship Criteria With ICH, GCP and Transparency Regulations

November 20, 2025November 16, 2025 digi

Aligning Publication Policies & Authorship Criteria With ICH, GCP and Transparency Regulations In the complex landscape of clinical research, especially concerning Crohn’s disease clinical trials, it is critical for professionals in clinical operations, regulatory affairs, and medical affairs to understand the integration of publication policies and authorship criteria with current regulations and guidelines. This article…

Publication Policies & Authorship Criteria

Publication Policies & Authorship Criteria Playbook for High-Profile and Late-Phase Trials

November 20, 2025November 16, 2025 digi

Publication Policies & Authorship Criteria Playbook for High-Profile and Late-Phase Trials Publication Policies & Authorship Criteria Playbook for High-Profile and Late-Phase Trials The integrity and transparency of clinical trials, especially in the context of ulcerative colitis clinical trials, are paramount in post-trial publication and dissemination of results. This guide is designed for clinical operations, regulatory…

Publication Policies & Authorship Criteria

ICFs, Assent & Short Forms in Practice: Step-by-Step Guide for Sponsors, CROs and Sites

November 20, 2025November 16, 2025 digi

ICFs, Assent & Short Forms in Practice: Step-by-Step Guide for Sponsors, CROs and Sites ICFs, Assent & Short Forms in Practice: Step-by-Step Guide for Sponsors, CROs and Sites The ethical execution of clinical trials is paramount, especially in studies involving vulnerable populations. Informed Consent Forms (ICFs), assent, and short forms are essential documents in this…

ICFs, Assent & Short Forms